SATISFYER_1170x120_8-13-20

Senate Finance Committee chairman Chuck Grassley (R

Pharmacy urges action to close DIR fee loophole

Pharmacy urges action to close DIR fee loophole

WASHINGTON – With the Senate Finance Committee holding a legislative markup today of the Prescription Drug Pricing Reduction Act (PDPRA) of 2019, eight associations noted initial bipartisan movement on direct and indirect remuneration (DIR) fee reform, but reiterated the need for swift and decisive action on this issue. Issuing a joint statement were: National Community